Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 13 May 2025 for Integra Lifesciences Holdings CORP. Read the official filing
Filing timeline
BuySaleChristian S. Schade
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+3.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Christian S. Schade: trading record in brief
This profile gathers the share dealings of Christian S. Schade across 2 companies, led by Aprea Therapeutics, Inc. and Integra Lifesciences Holdings Corp. Between 14 May 2021 and 9 May 2025, the trades on record add up to 10 filings.
No open-market sale appears; the market trades are 1 purchase worth €23k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 9 share grants.
Most recently, on 13 May 2025, the filings show a share grant in Integra Lifesciences Holdings Corp. The most recent open-market purchase was published on 19 May 2022, 1,613 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christian S. Schade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
6,939 shares0Common StockSEC:0000917520-25-000044:0
8,696 shares0Common StockSEC:0001628280-24-022923:0
4,486 shares0Common StockSEC:0001209191-23-029792:0
32,400 shares0Common StockSEC:0001104659-22-084772:0
65,770 shares@ US$0.8050.83% mcap46.5% of flowCommon StockSEC:0001104659-22-069015:0
37,500 shares@ US$0.64330.39% mcap21.7% of flowCommon StockSEC:0001104659-22-062916:0
Canonical exit: 16 Aug 2022 (T+90)
1,265 shares0Common StockSEC:0001209191-22-029707:0
100,100 shares0Common StockSEC:0001104659-22-033393:0
21,644 shares@ US$1.740.56% mcap31.8% of flowCommon StockSEC:0001104659-22-028767:0
530 shares0Common StockSEC:0001209191-21-033148:0
10 of 10 declarations
